Daiichi Sankyo Hires Swiss-Firm Lonza To Make Antibody Compounds
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo and Swiss-based Lonza have formed a venture with Kyowa Hakko Kirin, which supplies Potelligent technology to Lonza, to synthesize test compounds for antibodies under development